Behavioural Rehabilitation Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type of Behavioural Disorder, By Healthcare Setting, By Treatment Method, By Region and Competition, 2020-2030F

Description

Global Behavioural Rehabilitation Market was valued at USD 225.42 billion in 2024 and is anticipated to project impressive growth in the forecast period with a CAGR of 6.07% through 2030. Behavioral rehabilitation is a psychotherapeutic technique employed to address specific learned behaviors that pose a threat to an individual's well-being. This approach encompasses counseling, medication, and a range of support services, including reinforcement, punishment, and modeling. Its aim is to modify an individual's psychological conditioning, reducing the occurrence of self-destructive and unhealthy behaviors. By identifying and addressing patterns associated with irritability, inappropriate actions, substance abuse, depression, anxiety, impulsivity, aggression, hyperactivity, and grief, behavioral rehabilitation equips individuals with effective strategies to manage their emotions and actions, treating personality, mood, and attention deficit disorders. Behavioral rehabilitation pertains to the post-treatment of acquired brain injuries, with a specific focus on addressing changes in the patient's emotional state. This form of treatment aids patients in acquiring skills to effectively manage inappropriate actions that may pose challenges to their family members, co-workers, friends, and others. Symptomatic manifestations such as increased irritability, mood swings, emotional lability, and engaging in inappropriate behaviors are among the issues that can be effectively addressed through behavioral rehabilitation.

Market Overview
Forecast Period	2026-2030
Market Size 2024	USD 225.42 Billion
Market Size 2030	USD 318.43 Billion
CAGR 2025-2030	6.07%
Fastest Growing Segment	Outpatient Behavioural Rehabilitation
Largest Market	North America

Key Market Drivers

Increase in the Prevalence of Mental Health Disorders

The rise in the prevalence of mental health disorders worldwide serves as a significant driver for the growth of the behavioral rehabilitation market. For instance, according to the NIH, over one in five U.S. adults-approximately 59.3 million people or 23.1% of the adult population-were living with a mental illness in 2022. This statistic highlights the widespread impact of mental health conditions across the country and underscores the urgent need for accessible, effective mental health services and support systems to address the growing demand for care. The emergence of various internet interventions for treating common mental disorders, particularly in remote patient monitoring and easy accessibility, along with the widespread adoption of cost-effective online counseling sessions, contribute to the accelerated market growth. For instance, in September 2023, Praesum Healthcare Services, LLC acquired Beacon Point Recovery Center, LLC, a behavioral health provider network based in Philadelphia, U.S. The acquisition aims to expand Praesum's footprint in the behavioral health sector and enhance access to quality mental health and addiction treatment services in the region. The increasing prevalence of anxiety, dementia, depression, and other psychological disorders among the population is a key driver for market growth. The growing preference for partial hospitalization programs (PHPs) among patients is bolstering market expansion. These multi-day programs, offered by rehabilitation centers and hospitals, aim to facilitate emotional regulation, conflict resolution, anger management, and substance abuse treatment. In line with this, various government and non-government organizations also organize camps to provide behavioral rehabilitation for individuals with post-traumatic stress disorder (PTSD) and drug addiction, thereby contributing to market growth. The availability of online counseling services acts as another growth-inducing factor. With the onset of the Covid-19 pandemic, individuals are increasingly adopting online platforms to access timely treatment and recovery support.

Key Market Challenges

Lack of Patient Enrollment

The lack of patient enrollment hinders the growth of behavioral rehabilitation programs. Patient enrollment refers to the process of recruiting and enrolling individuals into these programs for treatment and intervention. This challenge can impact the effectiveness, reach, and sustainability of behavioral rehabilitation efforts. Low patient enrollment can result in a limited number of individuals accessing behavioral rehabilitation services. This restricts the availability of treatment options for those in need and can contribute to unmet mental health and behavioral health needs. Behavioral rehabilitation programs often require significant resources, including trained professionals, facilities, and support staff. A lack of patient enrollment means that these resources might be underutilized, leading to inefficiencies and decreased cost-effectiveness. Many behavioral rehabilitation programs rely on patient fees, insurance reimbursements, or government funding to operate. A lack of patient enrollment can strain the financial sustainability of programs, potentially leading to reduced services or closure.

Key Market Trends

Increasing Number of Digital Detoxification Programs

The growing prevalence of digital detoxification programs is a significant driver of market growth in the behavioral rehabilitation sector. Internet and social media addictions have seen a surge due to global technological advancements, impacting individuals, particularly teenagers and young adults who are tech-savvy. Digital detox programs play a crucial role in addressing internet addiction, with the Chinese government taking the lead in implementing boot camps specifically targeting young adults. The focus on digital detoxification programs in Asia is expected to prompt other countries worldwide to follow suit, resulting in an increased number of digital rehabilitation programs and driving market growth throughout the forecast period.

Key Market Players

Allergan, Inc.

Novartis AG

Taro Pharmaceutical Industries

Perrigo Company plc

Zynerba Pharmaceuticals

Apotex Inc.

Sandoz AG

Strides Arcolab Ltd.

TOLMAR Pharmaceuticals, Inc.

Limbix Health Inc

Report Scope:

In this report, the Global Behavioural Rehabilitation Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Behavioural Rehabilitation Market, By Type of Behavioural Disorder:

Anxiety Disorder
Mood Disorder
Substance Abuse Disorder
Personality Disorder
Attention Deficit Disorder

Behavioural Rehabilitation Market, By Healthcare Setting:

Outpatient Behavioural Rehabilitation
Inpatient Behavioural Rehabilitation
Residential Behavioural Rehabilitation

Behavioural Rehabilitation Market, By Treatment Method:

Counselling
Medication
Support Services
Other Treatment Methods

Behavioural Rehabilitation Market, By Region:

North America
- United States
- Canada
- Mexico
Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
Asia-Pacific
- China
- India
- Japan
- Australia
- South Korea
South America
- Brazil
- Argentina
- Colombia
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Behavioural Rehabilitation Market.

Available Customizations:

Global Behavioural Rehabilitation market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validations
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Behavioural Rehabilitation Market Outlook

5.1. Market Size & Forecast
- 5.1.1. By Value
5.2. Market Share & Forecast
- 5.2.1. By Type of Behavioural Disorder (Anxiety Disorder, Mood Disorder, Substance Abuse Disorder, Personality Disorder, and Attention Deficit Disorder)
- 5.2.2. By Healthcare Setting (Outpatient Behavioural Rehabilitation, Inpatient Behavioural Rehabilitation, and Residential Behavioural Rehabilitation)
- 5.2.3. By Treatment Method (Counselling, Medication, Support Services, and Other Treatment Methods)
- 5.2.4. By Region
- 5.2.5. By Company (2024)
5.3. Market Map

6. North America Behavioural Rehabilitation Market Outlook

6.1. Market Size & Forecast
- 6.1.1. By Value
6.2. Market Share & Forecast
- 6.2.1. By Type of Behavioural Disorder
- 6.2.2. By Healthcare Setting
- 6.2.3. By Treatment Method
- 6.2.4. By Country
6.3. North America: Country Analysis
- 6.3.1. United States Behavioural Rehabilitation Market Outlook
  - 6.3.1.1. Market Size & Forecast
    - 6.3.1.1.1. By Value
  - 6.3.1.2. Market Share & Forecast
    - 6.3.1.2.1. By Type of Behavioural Disorder
    - 6.3.1.2.2. By Healthcare Setting
    - 6.3.1.2.3. By Treatment Method
- 6.3.2. Canada Behavioural Rehabilitation Market Outlook
  - 6.3.2.1. Market Size & Forecast
    - 6.3.2.1.1. By Value
  - 6.3.2.2. Market Share & Forecast
    - 6.3.2.2.1. By Type of Behavioural Disorder
    - 6.3.2.2.2. By Healthcare Setting
    - 6.3.2.2.3. By Treatment Method
- 6.3.3. Mexico Behavioural Rehabilitation Market Outlook
  - 6.3.3.1. Market Size & Forecast
    - 6.3.3.1.1. By Value
  - 6.3.3.2. Market Share & Forecast
    - 6.3.3.2.1. By Type of Behavioural Disorder
    - 6.3.3.2.2. By Healthcare Setting
    - 6.3.3.2.3. By Treatment Method

7. Europe Behavioural Rehabilitation Market Outlook

7.1. Market Size & Forecast
- 7.1.1. By Value
7.2. Market Share & Forecast
- 7.2.1. By Type of Behavioural Disorder
- 7.2.2. By Healthcare Setting
- 7.2.3. By Treatment Method
- 7.2.4. By Country
7.3. Europe: Country Analysis
- 7.3.1. Germany Behavioural Rehabilitation Market Outlook
  - 7.3.1.1. Market Size & Forecast
    - 7.3.1.1.1. By Value
  - 7.3.1.2. Market Share & Forecast
    - 7.3.1.2.1. By Type of Behavioural Disorder
    - 7.3.1.2.2. By Healthcare Setting
    - 7.3.1.2.3. By Treatment Method
- 7.3.2. United Kingdom Behavioural Rehabilitation Market Outlook
  - 7.3.2.1. Market Size & Forecast
    - 7.3.2.1.1. By Value
  - 7.3.2.2. Market Share & Forecast
    - 7.3.2.2.1. By Type of Behavioural Disorder
    - 7.3.2.2.2. By Healthcare Setting
    - 7.3.2.2.3. By Treatment Method
- 7.3.3. Italy Behavioural Rehabilitation Market Outlook
  - 7.3.3.1. Market Size & Forecast
    - 7.3.3.1.1. By Value
  - 7.3.3.2. Market Share & Forecast
    - 7.3.3.2.1. By Type of Behavioural Disorder
    - 7.3.3.2.2. By Healthcare Setting
    - 7.3.3.2.3. By Treatment Method
- 7.3.4. France Behavioural Rehabilitation Market Outlook
  - 7.3.4.1. Market Size & Forecast
    - 7.3.4.1.1. By Value
  - 7.3.4.2. Market Share & Forecast
    - 7.3.4.2.1. By Type of Behavioural Disorder
    - 7.3.4.2.2. By Healthcare Setting
    - 7.3.4.2.3. By Treatment Method
- 7.3.5. Spain Behavioural Rehabilitation Market Outlook
  - 7.3.5.1. Market Size & Forecast
    - 7.3.5.1.1. By Value
  - 7.3.5.2. Market Share & Forecast
    - 7.3.5.2.1. By Type of Behavioural Disorder
    - 7.3.5.2.2. By Healthcare Setting
    - 7.3.5.2.3. By Treatment Method

8. Asia-Pacific Behavioural Rehabilitation Market Outlook

8.1. Market Size & Forecast
- 8.1.1. By Value
8.2. Market Share & Forecast
- 8.2.1. By Type of Behavioural Disorder
- 8.2.2. By Healthcare Setting
- 8.2.3. By Treatment Method
- 8.2.4. By Country
8.3. Asia-Pacific: Country Analysis
- 8.3.1. China Behavioural Rehabilitation Market Outlook
  - 8.3.1.1. Market Size & Forecast
    - 8.3.1.1.1. By Value
  - 8.3.1.2. Market Share & Forecast
    - 8.3.1.2.1. By Type of Behavioural Disorder
    - 8.3.1.2.2. By Healthcare Setting
    - 8.3.1.2.3. By Treatment Method
- 8.3.2. India Behavioural Rehabilitation Market Outlook
  - 8.3.2.1. Market Size & Forecast
    - 8.3.2.1.1. By Value
  - 8.3.2.2. Market Share & Forecast
    - 8.3.2.2.1. By Type of Behavioural Disorder
    - 8.3.2.2.2. By Healthcare Setting
    - 8.3.2.2.3. By Treatment Method
- 8.3.3. Japan Behavioural Rehabilitation Market Outlook
  - 8.3.3.1. Market Size & Forecast
    - 8.3.3.1.1. By Value
  - 8.3.3.2. Market Share & Forecast
    - 8.3.3.2.1. By Type of Behavioural Disorder
    - 8.3.3.2.2. By Healthcare Setting
    - 8.3.3.2.3. By Treatment Method
- 8.3.4. South Korea Behavioural Rehabilitation Market Outlook
  - 8.3.4.1. Market Size & Forecast
    - 8.3.4.1.1. By Value
  - 8.3.4.2. Market Share & Forecast
    - 8.3.4.2.1. By Type of Behavioural Disorder
    - 8.3.4.2.2. By Healthcare Setting
    - 8.3.4.2.3. By Treatment Method
- 8.3.5. Australia Behavioural Rehabilitation Market Outlook
  - 8.3.5.1. Market Size & Forecast
    - 8.3.5.1.1. By Value
  - 8.3.5.2. Market Share & Forecast
    - 8.3.5.2.1. By Type of Behavioural Disorder
    - 8.3.5.2.2. By Healthcare Setting
    - 8.3.5.2.3. By Treatment Method

9. South America Behavioural Rehabilitation Market Outlook

9.1. Market Size & Forecast
- 9.1.1. By Value
9.2. Market Share & Forecast
- 9.2.1. By Type of Behavioural Disorder
- 9.2.2. By Healthcare Setting
- 9.2.3. By Treatment Method
- 9.2.4. By Country
9.3. South America: Country Analysis
- 9.3.1. Brazil Behavioural Rehabilitation Market Outlook
  - 9.3.1.1. Market Size & Forecast
    - 9.3.1.1.1. By Value
  - 9.3.1.2. Market Share & Forecast
    - 9.3.1.2.1. By Type of Behavioural Disorder
    - 9.3.1.2.2. By Healthcare Setting
    - 9.3.1.2.3. By Treatment Method
- 9.3.2. Argentina Behavioural Rehabilitation Market Outlook
  - 9.3.2.1. Market Size & Forecast
    - 9.3.2.1.1. By Value
  - 9.3.2.2. Market Share & Forecast
    - 9.3.2.2.1. By Type of Behavioural Disorder
    - 9.3.2.2.2. By Healthcare Setting
    - 9.3.2.2.3. By Treatment Method
- 9.3.3. Colombia Behavioural Rehabilitation Market Outlook
  - 9.3.3.1. Market Size & Forecast
    - 9.3.3.1.1. By Value
  - 9.3.3.2. Market Share & Forecast
    - 9.3.3.2.1. By Type of Behavioural Disorder
    - 9.3.3.2.2. By Healthcare Setting
    - 9.3.3.2.3. By Treatment Method

10. Middle East and Africa Behavioural Rehabilitation Market Outlook

10.1. Market Size & Forecast
- 10.1.1. By Value
10.2. Market Share & Forecast
- 10.2.1. By Type of Behavioural Disorder
- 10.2.2. By Healthcare Setting
- 10.2.3. By Treatment Method
- 10.2.4. By Country
10.3. MEA: Country Analysis
- 10.3.1. South Africa Behavioural Rehabilitation Market Outlook
  - 10.3.1.1. Market Size & Forecast
    - 10.3.1.1.1. By Value
  - 10.3.1.2. Market Share & Forecast
    - 10.3.1.2.1. By Type of Behavioural Disorder
    - 10.3.1.2.2. By Healthcare Setting
    - 10.3.1.2.3. By Treatment Method
- 10.3.2. Saudi Arabia Behavioural Rehabilitation Market Outlook
  - 10.3.2.1. Market Size & Forecast
    - 10.3.2.1.1. By Value
  - 10.3.2.2. Market Share & Forecast
    - 10.3.2.2.1. By Type of Behavioural Disorder
    - 10.3.2.2.2. By Healthcare Setting
    - 10.3.2.2.3. By Treatment Method
- 10.3.3. UAE Behavioural Rehabilitation Market Outlook
  - 10.3.3.1. Market Size & Forecast
    - 10.3.3.1.1. By Value
  - 10.3.3.2. Market Share & Forecast
    - 10.3.3.2.1. By Type of Behavioural Disorder
    - 10.3.3.2.2. By Healthcare Setting
    - 10.3.3.2.3. By Treatment Method

11. Market Dynamics

11.1. Drivers
11.2. Challenges

12. Market Trends & Developments

12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments

13. Porter's Five Forces Analysis

13.1. Competition in the Industry
13.2. Potential of New Entrants
13.3. Power of Suppliers
13.4. Power of Customers
13.5. Threat of Substitute Products

14. Competitive Landscape

14.1. Allergan, Inc.
- 14.1.1. Business Overview
- 14.1.2. Company Snapshot
- 14.1.3. Products & Services
- 14.1.4. Financials (As Reported)
- 14.1.5. Recent Developments
- 14.1.6. Key Personnel Details
- 14.1.7. SWOT Analysis
14.2. Novartis AG
14.3. Taro Pharmaceutical Industries
14.4. Perrigo Company plc
14.5. Zynerba Pharmaceuticals
14.6. Apotex Inc.
14.7. Sandoz AG
14.8. Strides Arcolab Ltd.
14.9. TOLMAR Pharmaceuticals, Inc.
14.10. Limbix Health Inc.